Education
About Us
Working with TipRanks
Follow Us
Theraclion SA (TCLIF)
:TCLIF
TCLIF Stock Chart & Stats
$0.32
$0.32(188135.29%)
At close: 4:00 PM EDT
$0.32
$0.32(188135.29%)
Day’s Range― - ―
52-Week Range$0.32 - $0.32
Previous CloseN/A
Volume1.00K
Average Volume (3M)0.00
Market Cap
$32.22M
Enterprise ValueN/A
Total Cash (Recent Filing)$4.17M
Total Debt (Recent Filing)$1.30M
Price to Earnings (P/E)―
Beta2.21
Next Earnings
Apr 23, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)-133.83K
Price to Sales (P/S)18.38
P/FCF Ratio-5.06
Enterprise Value/Market Cap0.00
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
TCLIF FAQ
What was Theraclion SA’s price range in the past 12 months?
Theraclion SA lowest stock price was $0.32 and its highest was $0.32 in the past 12 months.
What is Theraclion SA’s market cap?
Theraclion SA’s market cap is $32.22M.
When is Theraclion SA’s upcoming earnings report date?
Theraclion SA’s upcoming earnings report date is Apr 23, 2026 which is in 175 days.
How were Theraclion SA’s earnings last quarter?
Currently, no data Available
Is Theraclion SA overvalued?
According to Wall Street analysts Theraclion SA’s price is currently Overvalued.
Does Theraclion SA pay dividends?
Theraclion SA does not currently pay dividends.
What is Theraclion SA’s EPS estimate?
Theraclion SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Theraclion SA have?
Currently, no data Available
What happened to Theraclion SA’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Theraclion SA?
Currently, no hedge funds are holding shares in TCLIF
Company Description
Theraclion SA
Theraclion SA develops echotherapy solutions using high intensity focused ultrasound system. It offers SONOVEIN, a robotic solution for non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment and protects the patient's skin and optimizes the image quality. The company was founded in 2004 and is based in Malakoff, France.
Technical Analysis
MAUNA KEA TECHNOLOGIES
―
Diagnostic Medical Systems
―
Ikonisys SA
―
Median Technologies
―
Implanet SA
―